These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 28970697)

  • 21. Influence of unreported HIV prophylaxis on the kinetics of post-blood donation HIV seroconversion.
    Nishiya AS; Salles NA; de Almeida-Neto C; Witkin SS; Ferreira SC; Nogueira FAH; Facincani T; Rocha V; Mendrone-Jr A
    Transfusion; 2021 Dec; 61(12):3488-3492. PubMed ID: 34617611
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Duration of time from onset of human immunodeficiency virus type 1 infectiousness to development of detectable antibody. The HIV Seroconversion Study Group.
    Petersen LR; Satten GA; Dodd R; Busch M; Kleinman S; Grindon A; Lenes B
    Transfusion; 1994 Apr; 34(4):283-9. PubMed ID: 8178324
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Assessing donor suitability for blood donation: Utility of Geenius HIV 1/2 confirmatory assay.
    Bujandric N; Grujic J; Budakov Obradovic Z
    Transfus Apher Sci; 2021 Feb; 60(1):103008. PubMed ID: 33183985
    [TBL] [Abstract][Full Text] [Related]  

  • 24. First report of human immunodeficiency virus transmission via an RNA-screened blood donation.
    Delwart EL; Kalmin ND; Jones TS; Ladd DJ; Foley B; Tobler LH; Tsui RC; Busch MP
    Vox Sang; 2004 Apr; 86(3):171-7. PubMed ID: 15078251
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Correlation of hepatitis C RNA and serum alanine aminotransferase in hepatitis B and C seronegative healthy blood donors.
    Ali N; Moiz B; Moatter T; Ahmed S; Adil SN; Khurshid M
    Indian J Pathol Microbiol; 2010; 53(3):480-5. PubMed ID: 20699507
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Estimating window period blood donations for human immunodeficiency virus Type 1, hepatitis C virus, and hepatitis B virus by nucleic acid amplification testing in Southern Pakistan.
    Moiz B; Moatter T; Shaikh U; Adil S; Ali N; Mahar F; Shamsuddin N; Khurshid M
    Transfusion; 2014 Jun; 54(6):1652-9. PubMed ID: 24383918
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Risk of human immunodeficiency virus (HIV) transmission by anti-HIV negative blood. Estimates using the lookback methodology.
    Kleinman S; Secord K
    Transfusion; 1988; 28(5):499-501. PubMed ID: 3420680
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Need for nucleic Acid testing in countries with high prevalence of transfusion-transmitted infections.
    Jain R; Aggarwal P; Gupta GN
    ISRN Hematol; 2012; 2012():718671. PubMed ID: 23008779
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Potential deferral criteria predictive of human immunodeficiency virus positivity among blood donors in Thailand.
    Kitayaporn D; Bejrachandra S; Chongkolwatana V; Chandanayingyong D; Weniger BG
    Transfusion; 1994 Feb; 34(2):152-7. PubMed ID: 8310487
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Nucleic acid amplification technology screening for hepatitis C virus and human immunodeficiency virus for blood donations.
    Bamaga MS; Bokhari FF; Aboud AM; Al-Malki M; Alenzi FQ
    Saudi Med J; 2006 Jun; 27(6):781-7. PubMed ID: 16758035
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Deceased organ donor screening for human immunodeficiency virus, hepatitis B virus and hepatitis C virus: Discordant serology and nucleic acid testing results.
    Theodoropoulos N; Nowicki MJ; Chinchilla-Reyes C; Dionne S; Jaramillo A; Mone T; Hasz R; Jendrisak MD; Ladner DP; Ison MG
    Transpl Infect Dis; 2018 Feb; 20(1):. PubMed ID: 29178242
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Trends in prevalence, incidence, and residual risk of major transfusion-transmissible viral infections in United Arab Emirates blood donors: impact of individual-donation nucleic acid testing, 2004 through 2009.
    Al Shaer L; AbdulRahman M; John TJ; AlHashimi A
    Transfusion; 2012 Nov; 52(11):2300-9. PubMed ID: 22691239
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Blood donor screening: how to decrease the risk of transfusion-transmitted hepatitis B virus?
    Niederhauser C; Mansouri Taleghani B; Graziani M; Stolz M; Tinguely C; Schneider P
    Swiss Med Wkly; 2008 Mar; 138(9-10):134-41. PubMed ID: 18330733
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Individual donor-nucleic acid testing for human immunodeficiency virus-1, hepatitis C virus and hepatitis B virus and its role in blood safety.
    Kumar R; Gupta S; Kaur A; Gupta M
    Asian J Transfus Sci; 2015; 9(2):199-202. PubMed ID: 26420945
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Safe-Testing Algorithm for Individual-Donation Nucleic Acid Testing: 10 Years of Experience in a Low-Prevalence Country.
    Stolz M; Gowland P; Tinguely C; Niederhauser C
    Transfus Med Hemother; 2019 Apr; 46(2):104-110. PubMed ID: 31191196
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Human immunodeficiency virus type 1 nucleic acids detected before p24 antigenemia in a blood donor.
    de Saussure P; Yerly S; Tullen E; Perrin LH
    Transfusion; 1993 Feb; 33(2):164-7. PubMed ID: 8430457
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sensitivity and specificity of a new automated system for the detection of hepatitis B virus, hepatitis C virus, and human immunodeficiency virus nucleic acid in blood and plasma donations.
    Galel SA; Simon TL; Williamson PC; AuBuchon JP; Waxman DA; Erickson Y; Bertuzis R; Duncan JR; Malhotra K; Vaks J; Huynh N; Pate LL
    Transfusion; 2018 Mar; 58(3):649-659. PubMed ID: 29250788
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Human immunodeficiency virus, hepatitis C and hepatitis B infections among blood donors in Germany 2000-2002: risk of virus transmission and the impact of nucleic acid amplification testing.
    Offergeld R; Faensen D; Ritter S; Hamouda O
    Euro Surveill; 2005 Feb; 10(2):8-11. PubMed ID: 15735310
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparative analysis of triplex nucleic acid test assays in United States blood donors.
    Stramer SL; Krysztof DE; Brodsky JP; Fickett TA; Reynolds B; Dodd RY; Kleinman SH
    Transfusion; 2013 Oct; 53(10 Pt 2):2525-37. PubMed ID: 23550838
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Risk of HIV-1 or 2 infection associated with transfusion in Benin].
    Zohoun A; Lafia E; Houinato D; Anagonou S
    Bull Soc Pathol Exot; 2004 Nov; 97(4):261-4. PubMed ID: 17304747
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.